Since the 1980s, Fenway Health has been a leader in HIV/AIDS prevention research and education. In that tradition, The Fenway Institute will soon serve as a site for two upcoming vaccine studies that have the potential to significantly reduce the number of new HIV infections: HVTN 106 and HVTN 110. HVTN 106 The first study, HVTN 106, will test four experimental vaccines against HIV by using DNA “primes” – DNA that can replicate the proteins found in HIV. The study vaccines are called DNA Nat-B env, DNA CON-S env, DNA Mosaic env, and MVA-CMDR. It’s important to note that theRead More
Subscribe To Fenway Focus
Fenway Health has served the LGBT community, those affected by HIV, and our other members of our community in Boston’s Fenway neighborhood and beyond for the last 40 years. Learn more about Fenway Health; our research arm, The Fenway Institute; and the Sidney Borum, Jr. Health Center, which provides safe, non-judgmental care for young people ages 12–29 who may not feel comfortable going anywhere else.
Affordable Care Act AIDS AIDS2012 AIDS Action Committee AIDS Walk Boston behavioral health bisexual Construction Update Events Fundraisers Gender identity Harbor to the Bay Health care Health Disparities HIV HIV/AIDS HIV/AIDS Policy HIV prevention HIV Research HIV testing International AIDS Conference Lesbian health LGBT advocacy LGBT Aging Project LGBT health LGBT Health Research LGBT seniors LGBT Youth Mentions in the news men who have sex with men National LGBT Health Education Center news Pre-Exposure Prophylaxis PrEP The Fenway Institute trans Transgender Transgender Awareness Week Transgender Health Trans Health Trans Women Health Violence Recovery Program Women's Health Young Leaders Council young people